文献速递母胎医学

范可尼贫血社群对产前干预的态度调查

Attitudes Toward Prenatal Interventions in the Fanconi Anemia Community
RSS 订阅 · Prenatal Diagnosis · 2026-02-19

本研究通过在线问卷调查范可尼贫血患者及照护者对产前诊断、宫内治疗和临床试验的态度。72名来自18个国家的成员完成调查,结果显示多数受访者对产前诊断和宫内治疗持积极态度。研究结果为推进宫内细胞与基因治疗临床试验提供支持。

要点

  • 76%受访者愿意接受FDA批准的宫内造血干细胞移植
  • 68%受访者会考虑参加评估宫内治疗安全性与有效性的临床试验
  • 71%受访者会在任何高危妊娠中接受侵入性产前检测以确认范可尼贫血

核心结论

  • 范可尼贫血社群对产前诊断和宫内治疗呈现积极态度,支持推进宫内细胞与基因治疗临床试验的发展。

研究设计与样本

  • 多学科团队通过范可尼贫血主要患者倡导组织创建并分发在线调查问卷。
  • 共72名来自18个国家的范可尼贫血社群成员完成调查。
  • 采用单变量有序逻辑回归分析受访者对产前诊断、宫内治疗和终止妊娠的态度。

主要发现

  • 76%的受访者表示如果宫内造血干细胞移植获得FDA批准,愿意接受该治疗。
  • 68%的受访者会考虑参加评估宫内造血干细胞移植或宫内基因治疗安全性与有效性的临床试验。
  • 71%的受访者会在任何高危妊娠中接受侵入性产前检测以确认范可尼贫血。
  • 56%的受访者不太可能终止已确诊为范可尼贫血的妊娠。

临床怎么用

  • 对范可尼贫血高危妊娠,可讨论侵入性产前检测的选择。
  • 宫内细胞与基因治疗作为新兴替代策略,需在临床试验框架下审慎开展并持续评估社群态度。

局限性

  • 电子调查存在固有局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ABSTRACT Objective In-utero cell and gene therapies may offer prenatal treatment options for inherited diseases. Preclinical data suggests in-utero (IU) hematopoietic stem cell transplantation (HSCT) could prevent Fanconi anemia (FA) related bone marrow failure without genotoxic conditioning or immune suppression. This study surveyed patient and caregiver attitudes within the FA community toward prenatal diagnosis, interventions, and clinical trials. Methods A multidisciplinary team created and distributed an online survey through the leading FA patient advocacy group. Respondents’ demographic, history, and treatment data were collected, and their attitudes toward prenatal diagnosis, IU therapies, and pregnancy termination were analyzed using univariable ordinal logistic regression. Results 72 members from 18 countries completed the survey. Among the respondents, 76% were willing to undergo IU-HSCT if it was FDA approved, whereas 68% would consider enrolling in a clinical trial to assess the safety and efficacy of IU-HSCT or IU-gene therapy. 71% would undergo invasive prenatal testing in any at risk pregnancy to confirm FA and 56% were unlikely to terminate an affected pregnancy. Conclusion In-utero therapy is a developing alternate treatment strategy for rare, inherited diseases. Although electronic surveys have inherent limitations, this tool enabled efficient assessment of FA community attitudes with a favorable response to prenatal diagnosis and therapies. These insights encourage efforts to advance IU-cell and gene therapy clinical trials and to continue to evaluate community attitudes as these therapies develop. This work may also provide insights into the attitudes of other rare inherited disease communities.

来源:Prenatal Diagnosis,查看原文。版权归原作者所有。

引用

  1. Prenatal Diagnosis:Attitudes Toward Prenatal Interventions in the Fanconi Anemia Community

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。